Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel in Refractory Rheumatoid Arthritis
NCT03082573Phase 4Unknown
- Sponsor
- Iraj Sabahi Research
- Start
- Mar 2017
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in rheumatoid arthritis (RA), sponsored by Iraj Sabahi Research. Status: unknown.
02
Drugs
repository corticotropin injection
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03082573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082573.